Expert Patient Self-management Programme Versus Usual Care in Bronchiectasis

Not Applicable

Completed

• Conditions: Bronchiectasis
• Interventions: Behavioral: Usual care; Behavioral: Expert Patient Programme

• Registration Number: NCT01117493
• Lead Sponsor: Belfast Health and Social Care Trust

Brief Summary

The aim of this exploratory randomized controlled trial was to investigate the efficacy of a disease specific Expert Patient Programme compared to usual care in patients with bronchiectasis. Hypothesis: Disease specific EPP will increase self efficacy compared to usual care.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-09
• Primary Completion: 2007-10
• Study Completion: 2007-10
• Status Verified: 2010-04
• Study First Submitted: 2010-05-04
• Study First Submitted QC: 2010-05-04
• Last Update Submitted: 2010-05-04
• Study First Posted: 2010-05-05
• Last Update Posted: 2010-05-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

• Adult patients (>18 years) with a primary diagnosis of bronchiectasis based on a respiratory physician's assessment including a computed tomography scan were included in the study

Exclusion Criteria

• Primary diagnosis of cystic fibrosis
• Patients with methicillin-resistant Staphylococcus aureus infection
• Patients with any condition that would have an impact on the assessment procedures (e.g. sensory impairment, pregnancy, language barriers)
• Any factor that would prevent adherence to the self-management programme.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Usual care	Usual care	Usual care included reviews at a specialist respiratory clinic on a three monthly basis to monitor spirometry, inflammatory blood markers and sputum microbiology. The patients were prescribed inhaled therapy and antibiotics if required, and treatment adjusted to the needs of the patient as necessary, including hospital admission.
Expert Patient Programme	Expert Patient Programme	Receives a disease specific Expert Patient Programme in addition to usual care. The disease specific Expert Patient Programme was delivered one session per week (lasting 2½ hours) for eight weeks and included 2 weeks disease specific education followed by 6 weeks standardised Expert Patient Programme.

Primary Outcome Measures

Name	Time	Method
Self-efficacy	8 months	Self efficacy is measured using the Chronic Disease Self Efficacy Scale. Confidence is measured on a 1-10 point Likert scale for 10 subscales. There are no specific units for this measurement.

Secondary Outcome Measures

Name	Time	Method
Perception of illness	8 months	Perception of illness is measured using the Illness Perception Questionnaire - revised IPQ-R. This questionnaire has 8 domains. Minimum score 52 and maximum 204. There are no specific units for this measurement.
Health related quality of life	8 months	Health related quality of life is measured using the St Georges Respiratory Questionnaire. This questionnaire has 3 domains. Min-max scores 0-100%
Self rated health	8 months	An expert patient programme questionnaire is used to record self rated health, management of condition, days lost to work and social activities, satisfaction and benefits. There are no specific units for this measurement.
Lung function	8 months	Spirometric measurement of FEV1 expressed as a percentage predicted is used to assess lung function
Rate of exacerbation	8 months	Frequency of antibiotics is recorded to assess rate of exacerbation. These will be expressed as the number of antibiotics prescribed per group during the study.